Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 4,698,771 5.600% | 1,577,906![]() (+50.56%) | Filing History |
| 2024-09-16 8:29 pm Unchanged | 2024-09-12 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,562,971 9.000% | 0 (Unchanged) | Filing History |
| 2024-07-22 4:18 pm Purchase | 2024-07-10 | 13G | Terns Pharmaceuticals, Inc. TERN | Citadel Advisors LLC | 3,410,764 5.300% | 3,410,764![]() (New Position) | Filing History |
| 2024-07-18 5:33 pm Sale | 2024-07-16 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,562,971 11.700% | -56,164![]() (-0.74%) | Filing History |
| 2024-06-07 1:30 pm Sale | 2024-05-31 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 3,120,865 4.800% | -288,113![]() (-8.45%) | Filing History |
| 2024-06-07 08:30 am Purchase | 2024-06-06 | 13G | Terns Pharmaceuticals, Inc. TERN | Soleus Capital Master Fund, L.P. | 3,341,120 5.200% | 3,341,120![]() (New Position) | Filing History |
| 2024-03-07 4:15 pm Purchase | 2024-03-06 | 13G | Terns Pharmaceuticals, Inc. TERN | Point72 Asset Management, L.P. | 3,921,226 6.300% | 3,921,226![]() (New Position) | Filing History |
| 2024-02-14 8:38 pm Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Venrock Healthcare Capital Partners III, L.P. | 4,497,117 7.300% | 789,226![]() (+21.29%) | Filing History |
| 2024-02-14 3:47 pm Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 6,632,015 9.900% | 1,362,728![]() (+25.86%) | Filing History |
| 2024-02-14 08:57 am Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 6,100,000 9.870% | 2,540,000![]() (+71.35%) | Filing History |
| 2024-02-13 5:21 pm Unchanged | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | LAV Biosciences Fund V L.P. | 2,901,566 4.700% | 0 (Unchanged) | Filing History |
| 2024-02-13 11:44 am Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,837,126 9.500% | 2,388,851![]() (+69.28%) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN | FMR LLC | 2,990,402 4.839% | -2,127,648![]() (-41.57%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 3,408,978 5.500% | 3,408,978![]() (New Position) | Filing History |
| 2024-01-25 4:09 pm Purchase | 2024-01-18 | 13G | Terns Pharmaceuticals, Inc. TERN | Integrated Core Strategies (US) LLC | 3,479,630 5.600% | 3,479,630![]() (New Position) | Filing History |
| 2023-10-13 3:58 pm Sale | 2023-10-09 | 13G | Terns Pharmaceuticals, Inc. TERN | FMR LLC | 5,118,050 8.380% | -2,260,591![]() (-30.64%) | Filing History |
| 2023-10-10 09:09 am Purchase | 2023-10-09 | 13G | Terns Pharmaceuticals, Inc. TERN | FIL Limited | 5,118,050 8.380% | 5,118,050![]() (New Position) | Filing History |
| 2023-10-04 5:09 pm Sale | 2023-10-04 | 13G | Terns Pharmaceuticals, Inc. TERN | Deerfield Mgmt, L.P. | 0 0.000% | -2,851,287![]() (Position Closed) | Filing History |
| 2023-07-28 4:25 pm Purchase | 2023-07-20 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 3,560,000 6.280% | 3,560,000![]() (New Position) | Filing History |
| 2023-06-27 4:32 pm Purchase | 2023-06-20 | 13G | Terns Pharmaceuticals, Inc. TERN | Millennium Management LLC | 2,313,370 4.100% | 2,313,370![]() (New Position) | Filing History |

